Early Disease and Low Baseline Damage as Predictors of Response to Belimumab in Patients With Systemic Lupus Erythematosus in a Real‐Life SettingMariele Gatto, Roberto Gerli, Anǵela Tincani et al.|Arthritis & Rheumatology|2020Cited by 113
Endothelial cells in tumor microenvironment: insights and perspectivesPatrizia Leone, Vito Racanelli|Frontiers in Immunology|2024Cited by 100
Antibiotics or No Antibiotics, That Is the Question: An Update on Efficient and Effective Use of Antibiotics in Dental PracticeAlessio Buonavoglia, Vito Racanelli|Antibiotics|2021Cited by 77